Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    August 2023

  1. Obesity and Heart Failure.
    N Engl J Med. 2023;389:e15.
    PubMed    


  2. SOHNS C, Fox H, Marrouche NF, Crijns HJGM, et al
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023 Aug 27. doi: 10.1056/NEJMoa2306037.
    PubMed     Abstract available


  3. MARTENS P, Mullens W
    Treating Iron Deficiency in Heart Failure.
    N Engl J Med. 2023 Aug 26. doi: 10.1056/NEJMe2308305.
    PubMed    


  4. MENTZ RJ, Garg J, Rockhold FW, Butler J, et al
    Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    N Engl J Med. 2023 Aug 26. doi: 10.1056/NEJMoa2304968.
    PubMed     Abstract available


  5. KOSIBOROD MN, Abildstrom SZ, Borlaug BA, Butler J, et al
    Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
    N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMoa2306963.
    PubMed     Abstract available


  6. PINTO YM
    Heart Failure with Preserved Ejection Fraction - A Metabolic Disease?
    N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMe2309294.
    PubMed    


    July 2023
  7. GARCIA-PAVIA P, Aus dem Siepen F, Donal E, Lairez O, et al
    Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
    N Engl J Med. 2023;389:239-250.
    PubMed     Abstract available


    April 2023
  8. CHANG LL, DesJardin JT, Albert MA, Ezekowitz J, et al
    Dietary Sodium Restriction in Patients with Heart Failure.
    N Engl J Med. 2023;388:1621-1623.
    PubMed    


    March 2023
  9. LEE DS, Ross HJ
    Trial of an Intervention to Improve Acute Heart Failure Outcomes. Reply.
    N Engl J Med. 2023;388:e46.
    PubMed    


  10. PELED H, Dau NQ
    Trial of an Intervention to Improve Acute Heart Failure Outcomes.
    N Engl J Med. 2023;388:e46.
    PubMed    


  11. FAN SC, Hsu NC
    Trial of an Intervention to Improve Acute Heart Failure Outcomes.
    N Engl J Med. 2023;388:e46.
    PubMed    


  12. HOUSTON BA, Brittain EL, Tedford RJ
    Right Ventricular Failure.
    N Engl J Med. 2023;388:1111-1125.
    PubMed    


  13. STONE GW, Abraham WT, Lindenfeld J, Kar S, et al
    Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.
    N Engl J Med. 2023 Mar 5. doi: 10.1056/NEJMoa2300213.
    PubMed     Abstract available


  14. SORAJJA P, Whisenant B, Hamid N, Naik H, et al
    Transcatheter Repair for Patients with Tricuspid Regurgitation.
    N Engl J Med. 2023 Mar 4. doi: 10.1056/NEJMoa2300525.
    PubMed     Abstract available


    January 2023
  15. SOLOMON SD, Vaduganathan M, McMurray JJV
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction. Reply.
    N Engl J Med. 2023;388:288.
    PubMed    


  16. GABRIELLI D, Oliva F, Zuccala G
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:287-288.
    PubMed    


  17. WEIR RAP
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:287.
    PubMed    


  18. REDFORS B, Omerovic E
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:286-287.
    PubMed    


  19. ZWECK E, Westenfeld R
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:286.
    PubMed    


  20. GOYAL P, Horn EM
    More COACHing Needed to Optimize Care after Heart Failure Hospitalization.
    N Engl J Med. 2023;388:82-83.
    PubMed    


    December 2022
  21. MULLENS W, Martens P
    Acute Decompensated Heart Failure, Volume, and Acetazolamide. Reply.
    N Engl J Med. 2022;387:2487.
    PubMed    


  22. FAUCHIER L, Maisons V, Halimi JM
    Acute Decompensated Heart Failure, Volume, and Acetazolamide.
    N Engl J Med. 2022;387:2486-2487.
    PubMed    


  23. KAPELIOS CJ, Drakos SG, Fang JC
    Acute Decompensated Heart Failure, Volume, and Acetazolamide.
    N Engl J Med. 2022;387:2486.
    PubMed    


  24. CULIC V
    Acute Decompensated Heart Failure, Volume, and Acetazolamide.
    N Engl J Med. 2022;387:2485-2486.
    PubMed    


    November 2022
  25. LEE DS, Straus SE, Farkouh ME, Austin PC, et al
    Trial of an Intervention to Improve Acute Heart Failure Outcomes.
    N Engl J Med. 2022 Nov 5. doi: 10.1056/NEJMoa2211680.
    PubMed     Abstract available


    October 2022
  26. PERERA D, Clayton T, O'Kane PD, Greenwood JP, et al
    Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2022;387:1351-1360.
    PubMed     Abstract available


  27. KIRTANE AJ
    REVIVE-ing a Weak Heart - Details Matter.
    N Engl J Med. 2022;387:1426-1427.
    PubMed    


    September 2022
  28. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.
    PubMed     Abstract available


    August 2022
  29. FELKER GM
    New Decongestion Strategies in an Evolving Heart Failure Landscape.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMe2209997.
    PubMed    


  30. SOLOMON SD, McMurray JJV, Claggett B, de Boer RA, et al
    Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2206286.
    PubMed     Abstract available


  31. MARGULIES KB
    DELIVERing Progress in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMe2210177.
    PubMed    


  32. MULLENS W, Dauw J, Martens P, Verbrugge FH, et al
    Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2203094.
    PubMed     Abstract available


    May 2022
  33. ANKER SD, Butler J, Packer M
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.
    N Engl J Med. 2022;386:e57.
    PubMed    


  34. HEERSPINK HJL, Inker L, Greene T
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    PubMed    


  35. AMATO J JR
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    PubMed    


  36. TRIPOSKIADIS FK, Xanthopoulos A, Iliodromitis EK
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    PubMed    


  37. BHATTACHARYYA D, Kar A, Dhumale S
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    PubMed    


    November 2021
  38. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    PubMed     Abstract available


    September 2021
  39. KITZMAN DW, Pastva AM, Mentz RJ
    Physical Rehabilitation in Patients with Heart Failure. Reply.
    N Engl J Med. 2021;385:1340-1341.
    PubMed    


  40. DUPONT J, Koppo K, Gielen E
    Physical Rehabilitation in Patients with Heart Failure.
    N Engl J Med. 2021;385:1340.
    PubMed    


  41. SCHUTTLER D, Weckbach LT, Brunner S
    Physical Rehabilitation in Patients with Heart Failure.
    N Engl J Med. 2021;385:1339-1340.
    PubMed    


  42. FRUSH BW
    Cool Water.
    N Engl J Med. 2021;385:1254-1255.
    PubMed    


    August 2021
  43. ANKER SD, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMoa2107038.
    PubMed     Abstract available


  44. DRAZNER MH
    SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable Foe.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMe2113008.
    PubMed    


  45. PACKER M, Butler J, Zannad F, Pocock SJ, et al
    Empagliflozin and Major Renal Outcomes in Heart Failure.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMc2112411.
    PubMed    


  46. JOYNT MADDOX KE, Orav EJ, Zheng J, Epstein AM, et al
    Year 1 of the Bundled Payments for Care Improvement-Advanced Model.
    N Engl J Med. 2021;385:618-627.
    PubMed     Abstract available


    May 2021
  47. TEERLINK JR, Felker GM, McMurray JJV
    Omecamtiv Mecarbil in Systolic Heart Failure. Reply.
    N Engl J Med. 2021;384:1967-1968.
    PubMed    


  48. BELLUMKONDA L
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    PubMed    


  49. BONAPACE S, Molon G
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    PubMed    


  50. KOMAMURA K
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1966-1967.
    PubMed    


  51. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    PubMed    


  52. ANKER SD, Coats AJS
    Exercise for Frail, Elderly Patients with Acute Heart Failure - A Strong Step Forward.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMe2106140.
    PubMed    


  53. KITZMAN DW, Whellan DJ, Duncan P, Pastva AM, et al
    Physical Rehabilitation for Older Patients Hospitalized for Heart Failure.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2026141.
    PubMed     Abstract available


    April 2021
  54. LEE TH
    Zoom Family Meeting.
    N Engl J Med. 2021;384:1586-1587.
    PubMed    


    January 2021
  55. PACKER M, Zannad F
    Empagliflozin in Heart Failure. Reply.
    N Engl J Med. 2021;384:387-388.
    PubMed    


  56. KUMAR S, Sinha S
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:387.
    PubMed    


  57. GERARD AO, Favre G, Esnault VLM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386-387.
    PubMed    


  58. SHANMUGANATHAN M, Goswami RM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386.
    PubMed    


  59. BHATTACHARYYA D, Kar A
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385-386.
    PubMed    


  60. FAUCHIER L, Fauchier G, Angoulvant D
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385.
    PubMed    


  61. LIN X, Wang S, Huang J
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:384-385.
    PubMed    


  62. SWEDBERG K
    Stimulation of Contractility in Systolic Heart Failure.
    N Engl J Med. 2021;384:178-179.
    PubMed    


  63. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    PubMed    


    November 2020
  64. BHATT DL, Szarek M, Steg PG, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030183.
    PubMed     Abstract available


  65. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
    Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2025797.
    PubMed     Abstract available


    October 2020
  66. ARMSTRONG PW, Anstrom KJ, O'Connor CM
    Vericiguat in Heart Failure with Reduced Ejection Fraction. Reply.
    N Engl J Med. 2020;383:1497-1498.
    PubMed    


  67. RYAN JJ, Maron BA
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1497.
    PubMed    


  68. WEARDEN J, Hough A, Kaiser S
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1496-1497.
    PubMed    


    August 2020
  69. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: